Department of Laboratory Medicine, Hallym University College of Medicine, Hwaseong, Korea.
Department of Laboratory Medicine, University of Ulsan College of Medicine and Asan Medical Center, Seoul, Korea.
Ann Lab Med. 2018 Sep;38(5):420-424. doi: 10.3343/alm.2018.38.5.420.
The urinary albumin/creatinine ratio (ACR) is an important indicator of albuminuria. We aimed to estimate ACR uncertainty and its impact on test results and proposed imprecision quality goals based on the estimated uncertainty.
The combined ACR uncertainty was calculated using the individual uncertainties of urinary albumin and creatinine. ACR confidence intervals (CIs) were estimated based on the expanded uncertainty. When the CI contained the ACR category boundary (30 or 300 mg/g), the cases were considered ambiguous. Quality goals for ACR were suggested using the number of ambiguous cases among actual patient results.
The number of ambiguous cases resulting from the combined ACR uncertainty was higher than expected based on biological variation (BV) quality goals. When the ACR met BV quality specifications, we estimated that 4.8-15.5% of the results may have been misclassified. To minimize the number of ambiguous results, the minimum, desirable, and optimum quality goals were set at 34.0%, 18.0%, and 4.5%, respectively.
We expressed ACR uncertainty using the uncertainties of urinary albumin and creatinine and assessed the impact of this combined uncertainty on the test results. Subsequently, we proposed imprecision quality goals for ACR based on ambiguous results.
尿白蛋白/肌酐比值(ACR)是白蛋白尿的重要指标。我们旨在根据估计的不确定性来估算 ACR 不确定性及其对测试结果的影响,并基于该不确定性提出不精密度质量目标。
采用尿白蛋白和肌酐的个体不确定性计算联合 ACR 不确定性。基于扩展不确定度估算 ACR 置信区间(CI)。当 CI 包含 ACR 类别边界(30 或 300mg/g)时,将这些情况视为模糊。使用实际患者结果中的模糊病例数来建议 ACR 的质量目标。
由于联合 ACR 不确定性导致的模糊病例数高于基于生物学变异(BV)质量目标的预期值。当 ACR 符合 BV 质量规范时,我们估计有 4.8-15.5%的结果可能被错误分类。为了最小化模糊结果的数量,最小、理想和最佳质量目标分别设定为 34.0%、18.0%和 4.5%。
我们使用尿白蛋白和肌酐的不确定性来表示 ACR 不确定性,并评估了这种联合不确定性对测试结果的影响。随后,我们基于模糊结果提出了 ACR 的不精密度质量目标。